Form 4: HealthEquity CFO Reports Future Stock Disposition for Tax Obligations

HealthEquity's EVP & CFO, James M. Lucania, reported a future disposition of 2,375 shares of common stock on July 3, 2025, at a price of $100.8721 per share, primarily for tax withholding.

Summary

• James M. Lucania, the Executive Vice President and Chief Financial Officer (EVP & CFO) of HealthEquity, Inc. (HQY), filed a Form 4.
• The filing reports a disposition of 2,375 shares of HealthEquity common stock.
• The transaction date for this disposition is July 3, 2025.
• The shares were disposed of at a price of $100.8721 per share.
• The transaction code 'F' indicates that the shares were disposed of to the issuer to satisfy tax withholding obligations.
• Following this reported transaction, James M. Lucania beneficially owns 89,429 shares of HealthEquity common stock directly.

Sentiment

Score: 5

Explanation: The sentiment is neutral as this is a routine, non-discretionary transaction for tax purposes, which is a common occurrence for executives receiving equity compensation. It does not indicate a positive or negative operational or strategic development for the company.

Positives

• The transaction is a routine disposition for tax withholding purposes, indicating a standard process for executive compensation.
• James M. Lucania retains a significant beneficial ownership of 89,429 shares, demonstrating continued alignment with shareholder interests.

Negatives

• The disposition of shares, while routine for tax purposes, represents a reduction in the executive's direct holdings.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic outlook. It solely reports a specific insider transaction.

Industry Context

This type of insider transaction (Form 4, Code F) is a common and routine occurrence across all publicly traded companies, typically related to the vesting of equity awards and the subsequent disposition of shares to cover tax obligations. It does not reflect broader industry trends or competitive positioning.

Stakeholder Impact

• Shareholders: The transaction is a routine tax-related disposition and is unlikely to have a significant direct impact on shareholders. The executive retains substantial ownership, which may be viewed positively as continued alignment of interests.

Key Dates

Keywords

HealthEquity, HQY, Form 4, insider transaction, stock disposition, executive compensation, tax withholding, CFO